loader
Please Wait
Applying Filters...
menu
    • menu

    Setid A74dc23d 02fb 4b31 B9ec 6c1039a39e8a Applno 22023 Form Powder Intravenous Dosage Eq 150mg Base Vial - Drug Product Composition: Fosaprepitant Dimeglumine

    Menu

    Fosaprepitant Dimeglumine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 20,819Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22023 / DOSAGE - POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FOSAPREPITANT DIMEGLUMINE(UNII: D35FM8T64X)
    (APREPITANT - UNII:1NF15YR6UY)     		APREPITANT150mg in 5

    Inactive Ingredients

    Ingredient Name
    Athenex Pharmaceutical Division, LLC.
    Lupin Pharmaceuticals, Inc.
    Meitheal Pharmaceuticals Inc.
    Merck Sharp & Dohme Corp.
    Mylan Institutional LLC
    SunGen Pharma, LLC
    anhydrous lactose(3SY5LH9PMK)
    EDETATE DISODIUM(7FLD91C86K)
    HYDROCHLORIC ACID(QTT17582CB)
    POLYSORBATE 80(6OZP39ZG8H)
    SODIUM HYDROXIDE(55X04QC32I)